These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7940878)

  • 21. Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine.
    Simonson SG; Raza A; Martin PD; Mitchell PD; Jarcho JA; Brown CD; Windass AS; Schneck DW
    Clin Pharmacol Ther; 2004 Aug; 76(2):167-77. PubMed ID: 15289793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Supplementation with anti-oxidants Vitamin C and E decreases cyclosporine A trough-levels in renal transplant recipients.
    de Vries AP; Oterdoom LH; Gans RO; Bakker SJ
    Nephrol Dial Transplant; 2006 Jan; 21(1):231-2. PubMed ID: 16115840
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetic analysis of Neoral conversion in pediatric and adult renal transplant recipients with poor absorption of Sandimmune.
    Pescovitz MD; Henson S; Bodziak K; Book BK; Gonin J; Jindal RM; Leapman SB; Milgrom ML; Filo RS
    Transplant Proc; 1996 Aug; 28(4):2165-8. PubMed ID: 8769189
    [No Abstract]   [Full Text] [Related]  

  • 24. Factors affecting compliance with cyclosporine in adult renal transplant patients.
    Sketris I; Waite N; Grobler K; West M; Gerus S
    Transplant Proc; 1994 Oct; 26(5):2538-41. PubMed ID: 7940782
    [No Abstract]   [Full Text] [Related]  

  • 25. Renal allograft infarction is a cause of early kidney transplant loss in the cyclosporine A era.
    Andrés A; Mazuecos A; Morales JM; Praga M; Martinez MA; Usera G; Araque A; Rodicio JL
    Transplant Proc; 1994 Oct; 26(5):2544-5. PubMed ID: 7940784
    [No Abstract]   [Full Text] [Related]  

  • 26. Does suboptimal immunosuppression contribute to chronic rejection?
    Simić S; Djukanović L; Stojković D; Balgojević R; Sinthoić M; Lezaić V; Radivojević D
    Transplant Proc; 1995 Feb; 27(1):909-10. PubMed ID: 7879226
    [No Abstract]   [Full Text] [Related]  

  • 27. Ten-year experience with low-dose cyclosporine A in renal transplantation.
    Wauters JP; Rosman JB; Descombes E; Genton A; Mosimann F
    Transplant Proc; 1994 Oct; 26(5):2528-9. PubMed ID: 7940777
    [No Abstract]   [Full Text] [Related]  

  • 28. Renal transplantation in elderly recipients.
    Andreu J; de la Torre M; Oppenheimer F; Campistol JM; Ricart MJ; Vilardell J; Talbot R; Carretero P
    Transplant Proc; 1992 Feb; 24(1):120-1. PubMed ID: 1539203
    [No Abstract]   [Full Text] [Related]  

  • 29. Increased resources are required in patients with low cyclosporine bioavailability.
    Schroeder TJ; Shah M; Hariharan S; First MR
    Transplant Proc; 1996 Aug; 28(4):2151-5. PubMed ID: 8769184
    [No Abstract]   [Full Text] [Related]  

  • 30. Incidence of noncutaneous malignancies in kidney transplant recipients: a 20-year follow-up.
    Mouquet C; Benalia H; Ourahma S; Barrou B; Bitker MO; Luciani J; Chatelain C; Viars P
    Transplant Proc; 1995 Apr; 27(2):1764. PubMed ID: 7725492
    [No Abstract]   [Full Text] [Related]  

  • 31. The influence of race and the impact of socioeconomic and clinical factors on primary renal allograft survival.
    Moosa MR; Grobbelaar C; Swanevelder SA; Edelstein CL
    Transplant Proc; 1992 Oct; 24(5):1754-6. PubMed ID: 1412826
    [No Abstract]   [Full Text] [Related]  

  • 32. Combined heart and kidney transplantation.
    Benvenuti C; Bourgeon B; Chopin D; Deleuze P; Aptecar E; Mourtada A; Baron C; Lebesneraie P; Remy P; Abbou C
    Transplant Proc; 1995 Apr; 27(2):1694. PubMed ID: 7725457
    [No Abstract]   [Full Text] [Related]  

  • 33. Single-dose response kinetics of oral cyclosporine A: a critical reexamination.
    Klauser R; Irschik H; Wolfram J; Woloszczuk W; Kovarik J
    Transplant Proc; 1992 Dec; 24(6):2610-3. PubMed ID: 1465883
    [No Abstract]   [Full Text] [Related]  

  • 34. Sandimmun neoral pharmacokinetics: impact of the new oral formulation.
    Holt DW; Mueller EA; Kovarik JM; van Bree JB; Richard F; Kutz K
    Transplant Proc; 1995 Feb; 27(1):1434-7. PubMed ID: 7878935
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetics of oral cyclosporine A in stable kidney transplant recipients: a critical review.
    Foradori AC; Martínez L; Elberg A; Vacarezza A; Loveluck A; Pinto C
    Transplant Proc; 1995 Apr; 27(2):1815-6. PubMed ID: 7725516
    [No Abstract]   [Full Text] [Related]  

  • 36. The interaction between clarithromycin and cyclosporine in kidney transplant recipients.
    Ferrari SL; Goffin E; Mourad M; Wallemacq P; Squifflet JP; Pirson Y
    Transplantation; 1994 Sep; 58(6):725-7. PubMed ID: 7940695
    [No Abstract]   [Full Text] [Related]  

  • 37. Economic analysis of Sandimmune Neoral in Canada in stable renal transplant patients.
    Keown P; Lawen JG; Landsberg D; Beauregard-Zollinger L; Rivière M; Leclerc C; Hardens M
    Transplant Proc; 1995 Apr; 27(2):1845-8. PubMed ID: 7725530
    [No Abstract]   [Full Text] [Related]  

  • 38. The adverse impact of high cyclosporine. Clearance rates on the incidences of acute rejection and graft loss.
    Lindholm A; Welsh M; Rutzky L; Kahan BD
    Transplantation; 1993 May; 55(5):985-93. PubMed ID: 8497912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporine blood concentrations in the management of renal transplant recipients.
    Rogerson ME; Marsden JT; Reid KE; Bewick M; Holt DW
    Transplantation; 1986 Feb; 41(2):276-8. PubMed ID: 3511588
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics of oral cyclosporine in children awaiting renal transplantation.
    Gusmano R; Verrina E; Piaggio G; Corbetta G; Basile GC; Perfumo F
    Transplant Proc; 1994 Oct; 26(5):2781-3. PubMed ID: 7940877
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.